Security key
00847X104
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO)
CUSIP: 00847X104
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, Par Value $0.001 per share
- Shares outstanding
- 59,431,072
- Total 13F shares
- 58,096,571
- Share change
- -200,924
- Total reported value
- $2,582,267,784
- Put/Call ratio
- 121%
- Price per share
- $44.43
- Number of holders
- 204
- Value change
- -$8,181,474
- Number of buys
- 100
- Number of sells
- 91
Report period
Q3 2024
Institutions
204
Top holders
10
AGIO full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
AGIOS PHARMACEUTICALS, INC. SEC filings
AGIOS PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00847X104
Recent filing periods:
Top shareholders of AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
9.5%
|
5,654,502
|
$243,822,126 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.2%
|
5,496,737
|
$237,019,300 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.2%
|
4,859,002
|
$209,520,165 | — | 30 Jun 2024 | |
| Bellevue Group AG |
13F
|
Company |
6.5%
|
3,879,548
|
$167,286,110 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.7%
|
2,777,259
|
$119,756,000 | — | 30 Jun 2024 | |
| Erste Asset Management GmbH |
13F
|
Company |
3.8%
|
2,254,900
|
$97,282,689 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
3.7%
|
2,196,085
|
$94,697,055 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.6%
|
2,114,949
|
$91,196,601 | — | 30 Jun 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3.5%
|
2,079,151
|
$89,652,991 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3%
|
1,776,145
|
$76,587,373 | — | 30 Jun 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2.9%
|
1,729,729
|
$74,586,000 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,351,430
|
$58,285,087 | — | 30 Jun 2024 | |
| BVF INC/IL |
13F
|
Company |
2%
|
1,190,107
|
$51,317,414 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1.9%
|
1,133,735
|
$48,886,654 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.8%
|
1,044,261
|
$45,028,534 | — | 30 Jun 2024 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1.7%
|
1,019,357
|
$43,954,674 | — | 30 Jun 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
1.5%
|
911,175
|
$39,290,000 | — | 30 Jun 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.5%
|
871,974
|
$37,599,519 | — | 30 Jun 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.2%
|
709,912
|
$30,611,404 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.1%
|
678,234
|
$29,245,450 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
662,236
|
$28,555,616 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1%
|
596,675
|
$25,728,626 | — | 30 Jun 2024 | |
| GW&K Investment Management, LLC |
13F
|
Company |
1%
|
595,066
|
$25,659,000 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.99%
|
586,266
|
$25,279,790 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.92%
|
549,003
|
$23,673,009 | — | 30 Jun 2024 | |
| Caligan Partners LP |
13F
|
Company |
0.87%
|
514,711
|
$22,194,338 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.78%
|
464,121
|
$20,012,896 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.77%
|
457,527
|
$19,728,564 | — | 30 Jun 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.76%
|
448,863
|
$19,355,000 | — | 30 Jun 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.75%
|
446,416
|
$19,249,458 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.71%
|
422,044
|
$18,198,537 | — | 30 Jun 2024 | |
| Eagle Health Investments LP |
13F
|
Company |
0.56%
|
330,830
|
$14,265,390 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.55%
|
326,780
|
$14,090,755 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.54%
|
322,882
|
$13,922,022 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.54%
|
320,531
|
$13,821,297 | — | 30 Jun 2024 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.54%
|
320,467
|
$13,818,537 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.53%
|
317,941
|
$13,709,616 | — | 30 Jun 2024 | |
| CenterBook Partners LP |
13F
|
Company |
0.42%
|
249,311
|
$10,750,290 | — | 30 Jun 2024 | |
| Laurion Capital Management LP |
13F
|
Company |
0.42%
|
248,395
|
$10,710,792 | — | 30 Jun 2024 | |
| NORGES BANK |
13F
|
Company |
0.41%
|
242,734
|
$10,466,690 | — | 30 Jun 2024 | |
| AXA S.A. |
13F
|
Company |
0.4%
|
238,682
|
$10,291,968 | — | 30 Jun 2024 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.38%
|
224,855
|
$9,866,637 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.38%
|
223,979
|
$9,657,974 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.38%
|
223,151
|
$9,622,270 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.35%
|
210,472
|
$9,075,553 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.3%
|
176,815
|
$7,624,263 | — | 30 Jun 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
174,870
|
$7,540,394 | — | 30 Jun 2024 | |
| Trexquant Investment LP |
13F
|
Company |
0.26%
|
155,076
|
$6,686,877 | — | 30 Jun 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.23%
|
137,844
|
$5,943,833 | — | 30 Jun 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.23%
|
136,838
|
$5,900,455 | — | 30 Jun 2024 |
Institutional Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) as of Q3 2024
As of 30 Sep 2024,
AGIOS PHARMACEUTICALS, INC. - Common Stock, Par Value $0.001 per share (AGIO) was held by
204 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,096,571 shares.
The largest 10 holders included
FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, BlackRock, Inc., Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, ARMISTICE CAPITAL, LLC, Erste Asset Management GmbH, JPMORGAN CHASE & CO, and MACQUARIE GROUP LTD.
This page lists
204
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
203
Q3 2024 holders
204
Holder diff
1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.